Featured Publications
Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis
Sterling J, Simhan J, Flynn B, Rusilko P, França W, Ramirez E, Angulo J, Martins F, Patel H, Higgins M, Swerdloff D, Nikolavsky D. Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis. Journal Of Urology 2024, 211: 596-604. PMID: 38275201, DOI: 10.1097/ju.0000000000003848.Peer-Reviewed Original ResearchDorsal onlay buccal mucosal graft urethroplastyBuccal mucosal graft urethroplastyRadiation therapyGraft urethroplastyUrethral stenosisUrinary incontinenceAnastomotic stenosisDevelopment of de novo stress urinary incontinenceRetrospective review of menInternational Prostate Symptom ScoreGlobal response assessmentProstate Symptom ScoreStress urinary incontinenceMedian follow-upVesicourethral anastomotic stenosisTreatment of urethral stenosisUrethral stricture diseasePatient-reported satisfactionRadical prostatectomyStenosis recurrencePatient-related outcomesProstate cancerRetrospective reviewSurgical complicationsSuprapubic catheter
2022
Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis.
Kong J, Lichtbroun B, Sterling J, Wang Y, Wang Q, Singer EA, Jang TL, Ghodoussipour S, Kim IY. Comparison of perioperative complications for extended vs standard pelvic lymph node dissection in patients undergoing radical prostatectomy for prostate cancer: a meta-analysis. American Journal Of Clinical And Experimental Urology 2022, 10: 73-81. PMID: 35528467, PMCID: PMC9077149.Peer-Reviewed Original ResearchPelvic lymph node dissectionLymph node dissectionRadical prostatectomyPerioperative complicationsRandom-effects modelProstate cancerSurgery subgroupNode dissectionComplication rateRisk ratioSubgroup analysisStandard pelvic lymph node dissectionTime of RPRobotic approachCochrane LibraryComplicationsSPLNDGreater riskPatientsAvailable evidencePooled dataAdditional studiesCancerSignificant differencesProstatectomyGenomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy
Kim IY, Mitrofanova A, Panja S, Sterling J, Srivastava A, Kim J, Kim S, Singer EA, Jang TL, Ghodoussipour S, Saraiya B, Mayer T, Sabaawy HE, Yuh B, Byun SS, Kim WJ, Horie S. Genomic analysis and long-term outcomes of a phase 1 clinical trial on cytoreductive radical prostatectomy. Prostate International 2022, 10: 75-79. PMID: 35510081, PMCID: PMC9035380, DOI: 10.1016/j.prnil.2022.03.001.Peer-Reviewed Original ResearchCytoreductive radical prostatectomyPhase 1 clinical trialLong-term outcomesProstate cancerRadical prostatectomyOncologic outcomesSystemic therapyClinical trialsMulticenter phase 1 trialLong-term oncologic outcomesAndrogen deprivation therapyPrimary end pointEvidence of diseaseMajor complication rateCombination of surgeryMajor inclusion criteriaPhase 1 trialMetastatic prostate cancerB prostate cancerTumor necrosis factorLong-term useMinority of menDeprivation therapyM1 diseaseClavien-Dindo
2020
Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience
Sterling J, Smith K, Farber N, Nagaya N, Jang TL, Singer EA, Sadimin E, Kim IY. Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience. Clinical Genitourinary Cancer 2020, 19: 275-279. PMID: 33153920, DOI: 10.1016/j.clgc.2020.09.006.Peer-Reviewed Original ResearchConceptsSystematic prostate biopsyProstate cancerProstate biopsyGleason scoreBiopsy resultsAnterior coreElevated prostate-specific antigenMagnetic resonance imaging-ultrasound fusion biopsyHigh-risk prostate cancerStandard template biopsyPercent of patientsSingle institution experienceC prostate cancerCsPCa detection ratesPositive biopsy resultsCancer detection rateSignificant prostate cancerProstate Imaging ReportingPI-RADS lesionsProstate-specific antigenTemplate prostate biopsyDetection rateMagnetic resonance imagingOverall detection rateSystematic biopsy